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Abstract
Objectives: The aim of this pilot study was to investigate associations between IL-6 and COX-2 expression in gingival
biopsies and both clinical diagnosis and genotypes in the IL-6 and COX-2 genes.
Design: A case-control study included 41 gingival biopsies obtained from Caucasian patients grouped according to clinical
diagnosis of gingival health (n = 10), gingivitis (n = 15) or chronic periodontitis (n = 16). Immunohistochemistry analyses were
performed to determine COX-2 expression in lamina propria, IL-6 expression in lamina propria and gingival epithelium and
level of inflammatory cell infiltrate. Individual DNA was extracted and genotyped by real-time PCR for IL6 SNPs rs 2069827
and rs 2069825 and for COX-2 rs 6681231.
Results: The percentage of cellular COX-2 expression was associated with the extent of periodontal disease (Arbes index
p= 0.026) and inflammatory infiltrate (p,0.0001). No association was observed between IL6 haplotypes and cells positive to
IL-6 or COX-2 in gingival tissues. The COX-2 rs 6681231 was associated with cells positive to IL-6 in the connective tissue
(p = 0.032).
Conclusions: COX-2 expression in gingival tissues may be a marker of periodontal disease severity. COX-2 rs 6681231 may
be associated with IL-6 local production in gingival tissues.
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Introduction
The systemic immune response, genetic factors and environ-
mental factors affect the risk of developing periodontitis [1,2]. In
recent years, studies have demonstrated that elevated levels of a
variety of inflammatory biomarkers [3,4] and genetic variants of
some cytokines confer susceptibility to periodontitis [5–7].
Interleukin-6 (IL-6) is a cytokine produced by lymphocytes,
monocytes, fibroblasts and endothelial cells, with functions in the
systemic inflammatory response and on regulation of the acute
phase response [8]. In particular, IL-6 is able to stimulate the
synthesis of all the acute phase proteins involved in the
inflammatory response C-reactive protein, serum amyloid A,
fibrinogen, a1-chymotrypsin and haptoglobin [9]. Cyclooxygen-
ase-2 (COX-2) is an enzyme involved in the conversion of
arachidonic acid to prostaglandins, with a consequent important
role in inflammatory responses, also in the periodontium [10,11].
COX-2 expression is induced by cytokines [12] and, on the other
hand, prostaglandins are important regulators of IL-6 production
by gingival fibroblasts [13]. Therefore, within the multitude of
actions on a wide range of cells and matrix structures in complex
organ systems, IL-6 and COX-2 have the potential to influence
one another.
A large number of scientific papers investigated the role of gene
variants (polymorphisms) in host responses in periodontitis, and in
the progression of the disease [14]. IL6 polymorphisms and
haplotypes have been shown to affect IL-6 transcription and
therefore circulating interleukin-6 levels [15–17]. A recent meta-
analysis of the IL6 2174 polymorphisms did not show any
association for this polymorphism with chronic periodontitis [14].
However, an association was found between IL-6 2174 and
aggressive periodontitis in a separate meta-analysis [18]. Similarly,
genetic regulation of COX-2 production has been associated with
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periodontitis [19]. Recently, a large study in Caucasians showed
an association between COX-2 rs 6681231 genetic polymorphism
and presence of aggressive periodontitis [20].
The objective of this pilot study was to investigate the
association between IL-6 and COX-2 expression in gingival
biopsies and both clinical presentation (disease severity) and
genetic polymorphisms in the IL6 and COX-2 genes.
Materials and Methods
Ethical considerations
All participants signed informed consent, and the study was
conducted in accordance with the Helsinki declaration (version
2002) and approved by the ethics/research committee of the
University of Granada (ref 04/072011).
Clinical examination and subject selection
A case-control and analytic study was conducted in 41 adults
requiring tooth extraction for caries, tooth fracture, endodontic
failure or tooth mobility (.1 mm in buccal-lingual direction and
cause of discomfort). Inclusion criteria were the same for all three
groups: Caucasian ethnicity, age .18 years and the presence of at
least 6 teeth. Exclusion criteria were periodontal treatment in the
previous year, antibiotics or anti-inflammatory treatment in the
previous 2 months and self-reported diagnosis of diabetes.
Demographic (age, gender) and clinical data were collected by a
calibrated examiner (R.M.). Gingival inflammation was assessed
using the gingival bleeding index [21] and probing depth and loss
of clinical attachment were determined using a PCPUNC15
periodontal probe (1 mm increments) (University of North
Carolina, Hu-Friedy, Chicago, IL), at six sites per tooth
(mesiovestibular, vestibular, distovestibular, mesiolingual, lingual,
and distolingual). CP extent was classified by the percentage of
sites with a loss of attachment $3 mm [22]. Following periodontal
examination, participants were grouped according to clinical
diagnosis of chronic periodontitis (CP), gingivitis (G), or gingival
health (control =C). For inclusion to this study:
N Chronic Periodontitis (CP) was classified by the presence of at
least 1 site with clinical attachment level (CAL) $3 mm and at
least 1 site with probing pocket depth (PPD) of $6 mm
N Gingivitis (G) was defined by any gingival bleeding on probing
(.0%) [21] and absence of PPD $3 mm
N Gingival health (C) was defined as no gingival bleeding on
probing [21] and absence of PPD $3 mm.
Each patient contributed with one site to the study sampling
procedures. All patients were treated with tooth extraction (and
periodontal treatment if appropriate) at the School of Dentistry,
University of Granada (Spain) from September 2010 to June 2011.
Immediately before the tooth extraction, the same clinician (F.M.)
used a scalpel to take a single biopsy from the mesial or distal
gingival papilla of each patient after anesthetization with 2%
mepivacaine. In CP patients, biopsies were obtained before tooth
extraction at sites with probing depth of $6 mm with bleeding on
probing and evidence of bone loss on periapical X-ray. In
gingivitis patients, biopsies were obtained before tooth extraction
at sites with bleeding on probing and PPD ,3 mm.
Examiner’s reproducibility
The examiner (author R.M.) was trained and calibrated on 10
patients probed twice before conducting periodontal examina-
tions. Intra-examiner reliability was assessed by using the kappa
statistic, which was equal to 0.78, evidencing a high degree of
consistency in the observations. The examiner was also calibrated
against a ‘gold-standard examiner’ (author F.M.) showing good
concordance, with a kappa statistics of 0.82.
Immunohistochemistry analyses
N COX-2 expression: Paraffin-embedded sections were de-
waxed, hydrated, and heat-treated in 1 mM EDTA buffer
pH 8 for antigenic unmasking in a PT module (Thermo Fisher
Scientific Inc., Waltham, MA) at 95uC during 20 min.
Sections were incubated for 30 min at room temperature with
anti-COX-2 (clone SP21) rabbit monoclonal antibody diluted
1:50 (Master Diagno´stica, Granada, Spain) in order to identify
cell inflammatory expression. The immunohistochemistry
study was done on an automatic immunostainer (Autostai-
ner480, Thermo Fisher Scientific Inc) using the polymer-
peroxidase-based method, followed by development with
diaminobenzidine (Master Diagno´stica). Appropriate positive
controls, as well as non-immune serum for negative controls,
were run concurrently. Nuclear counterstaining was done
using hematoxylin (Master Diagno´stica). The immunohisto-
chemistry results were calculated as percentage of cells positive
to COX-2 and semi-quantitatively using a 0 to 3 scale (0,
absence; 1, mild [,10% of cells positives]; 2, moderate [10 to
25%]; 3, severe [.25%]).
N IL-6 expression: Five-micrometre thick sections were exposed
to immunohistochemistry staining using the polyclonal
Table 1. Comparison between groups of studied periodontal, immunohistochemistry and genetic variables (n = 41).
Variables Control (n = 10) Gingivitis (n =15) Periodontitis (n = 16) p-value
Age (years) 35.2614.7 46.6617.9 44.969.4 0.112b
Gender (male) 7 (77.8%) 6 (50.0%) 11 (68.8%) 0.469a
Bleeding on probing %* 0 10.266.9 60.6625.2 ,0.001c
IL-6 H+ 5 (55.6%) 5 (45.5%) 4 (40.0%) 0.790a
IL-6 H2 4 (44.4%) 6 (54.5%) 6 (60.0%)
COX-2 genotype GC 1 (12.5%) 5 (38.5%) 6 (46.2%) 0.280a
COX-2 genotype CC 7 (87.8%) 8 (61.5%) 7 (53.8%)
Continuous values are expressed as mean 6 standard deviation;
a: Chi square test;
b: Kruskal-Wallis test;
c: Mann-Whitney U-test. Please note: Genotype results are available in 30/41 subjects for IL6 genotypes and in 34/41 subjects for COX-2 genotype.
doi:10.1371/journal.pone.0087023.t001
COX-2 Genotype and IL-6 Periodontal Tissue Levels
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antibody against human IL-6 (sc-130326), Santa Cruz
Biotechnology Inc., Germany) as described before [23]. The
histological measurements were performed using a microscope
(Olympus BX50, Best Scientific LTD, Wroughton, UK)
equipped with an imaging system (Image Pro-PLUS 4.5,
Media Cybernetics, Bethesda, USA). Each slide was catego-
rised into two zones: infiltrated connective tissue (ICT) and
periphery of the ICT (non-ICT). A 400-point lattice was
superimposed over the tissue area at a magnification of6400,
and the number of cross-points on positive cells was counted in
duplicate and expressed as a percentage of the tissue area
related to the total number of points [23].
Histological evaluation of the inflammatory infiltrate
The presence of inflammatory cells (namely lymphocytes,
granulocytes, monocytes/macrophages and plasma cells) in the
specimens was detected microscopically and recorded. The
inflammatory infiltrate level was calculated microscopically in a
semi-quantitatively manner on a 4-point scale: 0, absence of any
such inflammatory cells: 1, mild [,10% of lamina propria
involved]; 2, moderate [10 to 25%]; 3, severe [.25%]).
Genetic analyses
DNA was extracted from histological sections with a commer-
cially-available kit (‘Recover All Total Nucleic Acid Isolation’, Life
Technologies, Paisley, UK) and genotyped for two polymorphisms
in the IL6 gene promoter region using the Applied Biosystems
7300 Real Time PCR System as previously described [24]. The
studied polymorphisms were rs 2069827 and rs 2069825 in the IL6
gene and rs 6681231 in the COX-2 gene. Homozygous subjects for
rs 2069827 G allele and rs 2069825 C allele (no deletion) were
defined as H+, while all other subjects were H- [25]. Duplicates
were added to each plate to test for error rates. Each clinical
sample was anonymously coded, so the immunohistochemistry
and genetic analyses were performed independently and blind to
clinical diagnosis.
Statistical analysis
A specific computer program (SPSS-Windows 20.0 program
SPSS IBM Inc, Chicago, IL) was used for the statistical analyses.
Data on IL-6 and COX-2 expression in gingival tissues were
plotted and their normal distribution was confirmed. After
descriptive analysis, non-parametric tests (Mann-Whitney U-test,
Kruskal Wallis) and Spearman’s Rho coefficient were used to
evaluate the associations between IL-6 and COX-2 expression in
gingival tissues (primary outcomes) and clinical diagnosis and IL-6
and COX-2 SNPs (explanatory variables). No formal sample size
calculation was performed due to the pilot nature of the study. The
potential effect of confounders such as gender and age was
explored. The a value was set at 0.05. The tests used are reported
in table footnotes.
Results
The study included 41 gingival biopsies obtained from 16
Caucasian patients with CP, 15 with G and 10 with gingival
health. Table 1 shows inter-group comparisons of demographic
and clinical variables (bleeding on probing) and genetic variables
(IL6 and COX-2). Table 2 shows histological results in patients
Table 2. Medians and inter-quartile range of clinical (Arbes index) and histological results for subjects divided by clinical diagnosis.
Variable Control (n =10) Gingivitis (n = 15) Periodontitis (n = 16)
Comparisons between
groups
Arbes index 2 2 18 (12–46) 2
Inflammatory cells detected 1 (10%) 15 (100%) 16 (100%) ,0.001a
Cox2 Plasma cells 0 (0–1) 12.5 (2.5–62.5) 40 (15–100) 0.009a
Cox2 Monocytes 1 (0–2) 10 (5–62.5) 40 (15–100) 0.009a
IL-6 connective tissue 12.25 (11–15) 10.75 (9–12.5) 13 (10–15) 0.346b
IL-6 epithelium 12.25 (7–18) 15.25 (14–20.5) 15 (9–20.5) 0.582b
a: Chi square test;
b: Kruskal-Wallis test.
doi:10.1371/journal.pone.0087023.t002
Figure 1. Panoramic microphotograph of gingival biopsies. A) Gingival health group; B) Gingivitis; C) Chronic periodontitis. (Hematoxylin-
eosin, original magnification62). (Bar 1000 mm).
doi:10.1371/journal.pone.0087023.g001
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divided by clinical diagnosis: COX-2 immunohistochemistry
expression in lamina propria (positive plasma cells and monocytes)
and IL-6 expression in lamina propria and gingival epithelium.
The mean 6 S.D. of percentage of sites with a loss of attachment
$3 mm (Arbes index) in the CP group was 24.8618.0. The mean
probing pocket depth at the sites where the biopsy specimens were
taken in CP patients was 7.1262.65 mm.
Immunohistochemistry outcomes
The clinical diagnosis was confirmed histopathologically, since
inflammatory cells in the specimens were detected in only 1 out of
10 healthy, 15/15 G and 16/16 CP cases (see figures 1 and 2). The
mean percentage of inflammatory cells in CP cases was
lymphocytes 85% (50% of which were mature plasma cells),
granulocytes 9%, and monocytes/macrophages 6% (data not
presented). Figure 3 and 4 show immunohistochemistry expression
of COX-2 and IL-6 respectively in the different study groups. The
number of IL-6 positive cells by immunohistochemistry was
similar across clinical diagnoses (CP, G, C). On the other hand,
COX-2 expression in plasma cells and monocytes was associated
with clinical diagnosis (both p= 0.009), with a gradient increase
from C to G and to CP (Table 2). The percentage of cellular
COX-2 expression was associated with disease severity measured
as Arbes index (p = 0.026) and inflammatory infiltrate level (rho
coefficient = 0.674, p,0.0001). A positive association was also
detected between inflammatory infiltrate severity and immuno-
histochemistry expression of COX-2 in plasma cells and mono-
cytes of gingival lamina propria (Rho= 0.569, p,0.0001;
Rho= 0.565, p,0.0001, respectively). No associations were
detected between immunohistochemistry outcomes and demo-
graphic factors (age and gender).
Genetic outcomes
No error rates were detected in the genetic analyses. However,
some of samples yielded a small concentration of DNA, which was
not suitable for genetic analysis and was not scored (15/82 IL-6
SNPs and 7/41 COX-2 SNP, overall 17.9%). The Hardy-
Weinberg equilibrium was satisfied for all three studied SNPs.
The COX-2 rs 6681231 did not show any correlation with
COX-2 expression at immunohistochemistry (p = 0.884) but was
associated with cells positive to IL-6 in the connective tissue
(Rho= 0.449, p= 0.032) (Table 3).
The IL6 haplotype was not associated with the number of IL-6
positive cells at immunohistochemistry (lamina propria p = 0.224,
epithelium p= 0.580, Mann-Whitney U-test) or plasma cells and
monocytes COX-2 expression (p= 0.307, p = 0.134, p = 0.191,
respectively). IL-6 connective and epithelium immunohistochem-
istry expression did not correlate with COX-2 expression total
percentage (Rho= 0.01, p= 0.944; Rho=0.01, p = 0.946), plasma
cells (Rho=20.06, p= 0.743; Rho=20.01, p = 0.940) and
monocytes (Rho= 0.009, p = 0.962; Rho=20.02, p = 0.904).
Discussion
This study showed a relationship between immunohistochem-
istry expression of COX-2 and periodontal pathology (gingivitis
and chronic periodontitis). Furthermore, it produced initial
evidence for a possible association between COX-2 genotype rs
6681231 and local IL-6 expression (measured as number of
Figure 2. Gingival epithelium and lamina propria with variable chronic inflammatory infiltrate. A) Mild infiltrate in gingival health group;
B) mild/moderate infiltrate in gingivitis; and C) severe infiltrate in sulcular epithelium in chronic periodontitis (Hematoxylin-eosin, original
magnification610). (Bar 100 mm).
doi:10.1371/journal.pone.0087023.g002
Figure 3. Representative microphotograph of COX-2 immunohistochemical expression (brown-stained) in gingival biopsies. A)
Gingival health group; B) Gingivitis; C) Chronic periodontitis (Polymer-peroxidase-based method, original magnification610).
doi:10.1371/journal.pone.0087023.g003
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periodontal connective tissue cells positive to IL-6 at immunohis-
tochemistry).
There is strong evidence that genetic, as well as environmental
factors, affect the onset and severity of periodontitis [1]. Despite
the publication of several genetic association studies in the field of
periodontitis, including recent GWAS (genome-wide association
studies), there is considerable uncertainty as to which genetic
variants predispose to periodontitis. IL6 gene promoter and COX-2
polymorphisms are some of a few promising genetic variants
studied in association with periodontitis in different populations
[20,26,27,28]. However, studies for independent validation of
these findings and functional studies showing the effect of these
genetic variants in inducing periodontal pathology are still lacking.
To the best of our knowledge, this is the first study conducted in
a Caucasian population investigating the possible effect of COX-2
and IL6 haplotypes on local expression of COX-2 and IL-6 in the
gingiva. Interestingly, all three studied patient groups (gingival
health, gingivitis and chronic periodontitis) exhibited a similar
average of IL-6 positive cells in the gingival biopsies, while COX-2
expression was significantly associated with periodontal disease
severity. The association between COX-2 periodontal expression
and periodontal pathology confirms a previous report from our
group [29] and others [30], highlighting the role of this enzyme in
periodontal destruction. However, it is not clear whether increased
production of COX-2 may predispose to periodontitis or if, on the
other hand, COX-2 increased expression is just a result of chronic
exposure to periodontopathogenic bacteria.
In the present study, the rare allele frequency of COX-2
polymorphism rs 6681231 (17.6%) was almost identical to the
frequency reported in the HapMap CEPH Utah reference
population of European ancestry (17.8%) (www.hapmap.org).
The rare G allele, which was enriched in chronic periodontitis
patients in the present study, was found to be associated with
aggressive periodontitis in a large North-European Caucasian
population [20]. This SNP was not associated with COX-2
expression in our sample, but showed an association with IL-6
cellular infiltrate in the connective tissue. Studies in Taiwanese
and Chinese populations [19,31] reported that the 2765 C
polymorphism of the COX-2 gene is associated with a decreased
risk for periodontitis in these populations, especially in aggressive
periodontitis. In contrast with this, functional analyses on COX-2
2765 polymorphism have reported that the C allele may reduce
the COX-2 gene expression and consequently inhibit inflamma-
tory responses [32,33]. A possible reason for the discrepancy is
that the clinical role of COX-2 in inflammation may be dual by
initiating the process of inflammation and then later aiding in its
resolution. The effects of COX-2 genotypes in the inflammatory
response through variations in COX-production have been shown
with relation to C-reactive protein [32] and IL-6 [34]. In
particular, PEG2 is important in regulating IL-6 production and
COX-2 inhibitors have been shown to be useful in controlling
fibroblast IL-6 production. The effect of COX-2 is particularly
important in gingival fibroblast IL-6 production [13], which would
explain the association observed in our study with IL-6 positive
cells in the connective tissue but not in the epithelial infiltrate. The
lack of association between COX-2 genetic polymorphisms and
COX-2 gingival expression may be due to the pilot nature of this
study, which might help in a sample size calculation for a future
study investigating this outcome.
In conclusion, this study confirms a possible role for COX-2 in
periodontal pathology and it is the first study to provide initial
evidence that the COX-2 rs 6681231 genotype may affect IL-6
local production in gingival tissues. Limitations of this study are
inherent to its pilot nature and include the small sample size, with
the risk of type II error and the residual potential confounding
effect of smoking. Therefore, the present findings need to be
confirmed by larger investigations. If these results were confirmed,
IL-6 may be considered an important mediator in the role of
COX-2 polymorphisms in periodontal pathology.
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Table 3. COX-2 gingival expression (median and inter-
quartile range) and IL-6 cells positive in the periodontal
connective tissue (CT) and outside CT in subjects divided by
COX-2 rs 6681231 genotypes.
Immunohistochemistry results
COX % IL-6 in CT
IL-6 outside
CT
COX-2 rs
6681231
genotypes
CC (n = 22) 10 (5–50) 13.5 (11–16.5)* 13 (6.5–20.5)
GC (n = 12) 10 (1–50) 10 (6.5–13)* 16.7 (13–25)
*P = 0.032 Mann-Whitney U test.
doi:10.1371/journal.pone.0087023.t003
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